Orsini - Rare Disease Pharmacy Solutions

In celebration of National Pharmacist Day this Sunday, we’re shining a spotlight on the heart and soul of our pharmacy team—our pharmacists. Hear directly from them about what makes their work so rewarding and why they're passionate about making a difference in the lives of others every day. #NationalPharmacistDay #PharmacyHeroes #NoPatientLeftBehind

Our team is eager to connect with clinicians, researchers, and industry partners who share our passion for improving rare disease patient care at Parent Project Muscular Dystrophy's #Duchenne Healthcare Professionals Summit next week. We hope to see you there! #PPMD #RareDisease #PatientCare #EndDuchenne

We're excited to announce our partnership with PicnicHealth, a health technology company dedicated to simplifying observational research in order to improve rare disease patient care and advance real-world study execution. To launch this venture, Orsini and PicnicHealth will partner with AstraZeneca, a global, science-led biopharmaceutical company, to gather insights on WAINUA™ (eplontersen). At Orsini, our mission is to leave no patient behind, and this partnership is another step forward in delivering on that promise. Together with PicnicHealth and AstraZeneca, we’re creating opportunities to better understand and support patients with innovative treatment. Read the press release here: https://bit.ly/41UfL2d #RareDiseaseCare #NoPatientLeftBehind #RealWorldData #PatientAdherence

Wishing our patients, partners, and team members a happy, healthy, and successful New Year! As we step into 2025, we reflect on the incredible stories of hope, resilience, and determination that have inspired us throughout the past year. Together, we’ve made a meaningful difference in the lives of patients and their families, and we’re committed to carrying our No Patient Left Behind mission forward into the New Year. #HappyNewYear #NoPatientLeftBehind #RareDiseaseCare

Happy Holidays 🎄 Our pharmacy will be closed on Christmas Day. Our dedicated clinicians are on call for urgent needs. We will reopen Thursday morning, ready to serve our patients with care. Wishing you a joyous holiday season!

Orsini is proud to be a specialty pharmacy partner selected by Ascendis Pharma for Yorvipath (palopegteriparatide). “We’re thrilled to add YORVIPATH to our growing portfolio of endocrinology therapies,” Darin DeCarlo, Orsini’s Chief Growth Officer, said. “Orsini is built to serve rare disease patients, and we're excited to partner with Ascendis to deliver this new treatment option to patients suffering from chronic hypoparathyroidism.” Read the press release: https://bit.ly/3Vvdfv0 #PatientCare #RareDisease #NoPatientLeftBehind

🦃 Happy Thanksgiving! 🦃 Our pharmacy will be closed today as we give thanks and spend time with loved ones. Our dedicated clinicians are always on call for urgent needs. We'll reopen Friday morning, ready to serve our patients and partners with gratitude and care. Have a wonderful Thanksgiving!

Orsini is proud to be a specialty pharmacy partner selected by BridgeBio for Attruby (acoramidis), an orally administered treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM). “Orsini is deeply embedded in the cardiomyopathy space, having supported patients suffering from the disorder for over five years,” Darin DeCarlo, Orsini’s Chief Growth Officer, said. “Our partnership with BridgeBio offers us a tremendous opportunity to bring new hope to the patients we serve.” Read the press release: https://lnkd.in/eedd4GE7 #ATTRCM #PatientCare #RareDisease #NoPatientLeftBehind

Leading the Way in Cell & Gene Therapy At Orsini, we’re proud to be the leading independent specialty pharmacy dispensing cell and gene therapies (CAGT). With 6 launched therapies—and more on the horizon—we’re dedicated to ensuring patients have access to these life-changing treatments. From navigating patient access challenges and managing ultra-cold chain logistics to providing exceptional support for treatment centers, Orsini is committed to advancing innovation and outcomes for patients receiving CAGT treatment. Watch this video to learn more about how our team supports the treatment journey: https://bit.ly/3YXTHAq #CellAndGeneTherapy #CAGT #CGT #SpecialtyPharmacy #RareDisease #NoPatientLeftBehind

We are proud to share that Vertex Pharmaceuticals has chosen Orsini to dispense gene-editing therapy CASGEVY® (exagamglogene autotemcel). Read the full press release here: https://bit.ly/4hBAvkz #NoPatientLeftBehind #CRISPR #CAGT #CGT